Compounds > magnoflorine
Page last updated: 2024-08-25

magnoflorine and Breast Neoplasms

magnoflorine has been researched along with Breast Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Peilong, C; Wei, T; Xiaojun, X1
Angelis, A; Baran, M; Dmoszynska-Graniczka, M; Guz, M; Halasa, M; Jarzab, A; Kalpoutzakis, E; Kukula-Koch, W; Okon, E; Stepulak, A; Wawruszak, A1

Other Studies

2 other study(ies) available for magnoflorine and Breast Neoplasms

ArticleYear
Magnoflorine improves sensitivity to doxorubicin (DOX) of breast cancer cells via inducing apoptosis and autophagy through AKT/mTOR and p38 signaling pathways.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2020, Volume: 121

    Topics: Animals; Antineoplastic Agents; Apoptosis; Aporphines; Autophagy; Breast Neoplasms; Cell Line; Cell Line, Tumor; Doxorubicin; Female; Humans; MCF-7 Cells; Mice; Mice, Inbred BALB C; Mice, Nude; p38 Mitogen-Activated Protein Kinases; Proto-Oncogene Proteins c-akt; Signal Transduction; TOR Serine-Threonine Kinases; Tumor Cells, Cultured

2020
Magnoflorine-Isolation and the Anticancer Potential against NCI-H1299 Lung, MDA-MB-468 Breast, T98G Glioma, and TE671 Rhabdomyosarcoma Cancer Cells.
    Biomolecules, 2020, 11-10, Volume: 10, Issue:11

    Topics: Antineoplastic Agents; Apoptosis; Aporphines; Berberis; Breast Neoplasms; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Survival; Female; Glioma; Humans; Plant Extracts; Rhabdomyosarcoma

2020